Eisai Launches "Spot Her," New Endometrial Cancer Initiative
By Teresa Cronin - Last Updated: May 10, 2023Teresa Cronin, Vice President of Corporate Communications and Patient Advocacy at Eisai Inc, spoke with Cancer Nursing Today about Spot Her, Eisai’s new endometrial cancer awareness and screening initiative.
Spot Her, a collaborative initiative with Force, Share, and Black Health Matters, aims to raise awareness about endometrial cancer. The campaign hopes to empower people across generations and cultures to identify the signs of the most common type of uterine cancer. Teresa Cronin discusses topics including diagnosis, resources, and eliminating the taboo of discussing “below the belt” health concerns.
Resources
Post Tags:ONS Congress 2023
Related Posts
Patients with ibrutinib dose reductions after AEs had longer treatments and similar outcomes to those without reductions.
Patients with CLL who relapsed after HSCT and then received venetoclax achieved outcomes consistent with trial data.
The rituximab, fludarabine, and cyclophosphamide regimen appeared to be most effective for overall survival and response.
Data suggest patients with CLL are more anxious when receiving intravenous versus oral treatment.
It is important to monitor patients who have elevated CMV levels to detect infection and progression early.
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.